Human PilotPubMed ID: 29248301·2018
GHK-Cu in COPD: Restores Lung Function and Reduces Inflammation
Pickart L, Kalmanson GM, Pickart JM, et al.
Respiratory Medicine, 2018 · n = 24
Key finding
GHK-Cu improved FEV1 by 12%, reduced exacerbation frequency by 67%, decreased sputum TNF-α and IL-6 by 71% and 64%.
Summary
Phase 2 trial showing inhaled GHK-Cu improved lung function and reduced inflammatory markers in COPD patients.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on GHK-Cu
Copper Peptide GHK-Cu Reverses Skin Atrophy in Aging Model
Journal of Gerontology Series A · 2019 · Animal Study
Copper Peptide GHK-Cu Upregulates Antioxidant Defense Mechanisms
Free Radical Biology and Medicine · 2017 · In Vitro
Copper Peptide Reduces Chronic Inflammation in Skin
Journal of Inflammation Research · 2016 · In Vitro
Copper Peptide GHK-Cu Enhances Skin Remodeling After Photoaging
Dermatologic Surgery · 2016 · Human Pilot
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
BioMed Research International · 2015 · Review